Olga Laosa

1.7k total citations
21 papers, 675 citations indexed

About

Olga Laosa is a scholar working on Geriatrics and Gerontology, Physiology and Economics and Econometrics. According to data from OpenAlex, Olga Laosa has authored 21 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Geriatrics and Gerontology, 10 papers in Physiology and 5 papers in Economics and Econometrics. Recurrent topics in Olga Laosa's work include Frailty in Older Adults (10 papers), Nutrition and Health in Aging (10 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Olga Laosa is often cited by papers focused on Frailty in Older Adults (10 papers), Nutrition and Health in Aging (10 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Olga Laosa collaborates with scholars based in Spain, United Kingdom and Italy. Olga Laosa's co-authors include Leocadio Rodríguez‐Mañas, Mariam El Assar, Alessandra Marengoni, Anna Giardini, Elı́sio Costa, Elaine Lehane, Enrica Menditto, Sërgio Pecorelli, Micah J. Savin and Alessandro Monaco and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nutrients and Age and Ageing.

In The Last Decade

Olga Laosa

21 papers receiving 655 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olga Laosa Spain 12 232 209 122 116 75 21 675
Craig Plauschinat United States 18 155 0.7× 234 1.1× 384 3.1× 148 1.3× 74 1.0× 29 1.3k
Amy Barton Pai United States 19 229 1.0× 57 0.3× 154 1.3× 113 1.0× 73 1.0× 54 1.2k
Victoria Rollason Switzerland 18 228 1.0× 114 0.5× 76 0.6× 126 1.1× 129 1.7× 50 1.3k
Jo E. Rodgers United States 20 115 0.5× 122 0.6× 102 0.8× 43 0.4× 49 0.7× 67 1.4k
Gayathri Kamalakkannan United States 6 138 0.6× 106 0.5× 192 1.6× 151 1.3× 38 0.5× 12 1.0k
Sanobar Parkar United States 11 153 0.7× 79 0.4× 246 2.0× 186 1.6× 80 1.1× 15 1.5k
Andreas D. Meid Germany 17 390 1.7× 60 0.3× 105 0.9× 240 2.1× 51 0.7× 59 830
Morten Hansen Denmark 17 216 0.9× 137 0.7× 87 0.7× 110 0.9× 37 0.5× 45 1.2k
Samar A. Nasser United States 19 93 0.4× 64 0.3× 130 1.1× 123 1.1× 48 0.6× 36 1.3k
Pernelle Noïze France 16 222 1.0× 44 0.2× 63 0.5× 127 1.1× 112 1.5× 62 840

Countries citing papers authored by Olga Laosa

Since Specialization
Citations

This map shows the geographic impact of Olga Laosa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Laosa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Laosa more than expected).

Fields of papers citing papers by Olga Laosa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Laosa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Laosa. The network helps show where Olga Laosa may publish in the future.

Co-authorship network of co-authors of Olga Laosa

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Laosa. A scholar is included among the top collaborators of Olga Laosa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Laosa. Olga Laosa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laosa, Olga, Eva Topinková, I. Bourdel‐Marchasson, et al.. (2025). Long-term frailty and physical performance transitions in older people with type-2 diabetes. The MIDFRAIL randomized clinical study. The journal of nutrition health & aging. 29(4). 100512–100512. 3 indexed citations
2.
Sinclair, Alan J., et al.. (2024). Disability and Quality of Life Measures in older frail and prefrail people with type 2 diabetes. The MIDFRAIL-Study. Diabetes Research and Clinical Practice. 214. 111797–111797. 3 indexed citations
3.
Álvarez‐Bustos, Alejandro, Olga Laosa, Emanuele Marzetti, et al.. (2024). Response rates and associated factors after a multicomponent intervention in frail older adults with diabetes. Age and Ageing. 53(1). 4 indexed citations
4.
Calvani, Riccardo, Anna Picca, Leocadio Rodríguez‐Mañas, et al.. (2023). Amino Acid Profiles in Older Adults with Frailty: Secondary Analysis from MetaboFrail and BIOSPHERE Studies. Metabolites. 13(4). 542–542. 11 indexed citations
5.
Bourdel‐Marchasson, Isabelle, Sophie Regueme, Mark Kelson, et al.. (2022). A Therapeutic Vibrating Insole Device for Postural Instability in Older People with Type 2 Diabetes: A Randomized Control Study. Diabetes Therapy. 13(5). 995–1006. 3 indexed citations
6.
Rodríguez-Sánchez, Isabel, Leocadio Rodríguez‐Mañas, & Olga Laosa. (2022). Long COVID-19. Clinics in Geriatric Medicine. 38(3). 533–544. 14 indexed citations
7.
8.
Izquierdo, Míkel, Olga Laosa, Eduardo Lusa Cadore, et al.. (2021). Two-Year Follow-up of a Multimodal Intervention on Functional Capacity and Muscle Power in Frail Patients With Type 2 Diabetes. Journal of the American Medical Directors Association. 22(9). 1906–1911. 22 indexed citations
9.
Laosa, Olga, et al.. (2020). Rapid Assessment at Hospital Admission of Mortality Risk From COVID-19: The Role of Functional Status. Journal of the American Medical Directors Association. 21(12). 1798–1802.e2. 27 indexed citations
10.
Peña-Longobardo, Luz María, Juan Oliva, Néboa Zozaya, et al.. (2020). Economic evaluation of a multimodal intervention in pre-frail and frail older people with diabetes mellitus: the MID-FRAIL project. Expert Review of Pharmacoeconomics & Outcomes Research. 21(1). 111–118. 12 indexed citations
11.
Calvani, Riccardo, Leocadio Rodríguez‐Mañas, Anna Picca, et al.. (2020). Identification of a Circulating Amino Acid Signature in Frail Older Persons with Type 2 Diabetes Mellitus: Results from the Metabofrail Study. Nutrients. 12(1). 199–199. 31 indexed citations
12.
Calvani, Riccardo, Leocadio Rodríguez‐Mañas, Anna Picca, et al.. (2019). The “Metabolic biomarkers of frailty in older people with type 2 diabetes mellitus” (MetaboFrail) study: Rationale, design and methods. Experimental Gerontology. 129. 110782–110782. 9 indexed citations
13.
Assar, Mariam El, Olga Laosa, & Leocadio Rodríguez‐Mañas. (2018). Diabetes and frailty. Current Opinion in Clinical Nutrition & Metabolic Care. 22(1). 52–57. 84 indexed citations
14.
Ramı́rez, Elena, Teresa Bellón, Hoi Y. Tong, et al.. (2016). Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/TEN are different from those found for the same AED-induced DRESS in the Spanish population. Pharmacological Research. 115. 168–178. 59 indexed citations
15.
Costa, Elı́sio, Sërgio Pecorelli, Anna Giardini, et al.. (2015). Interventional tools to improve medication adherence: review of literature. Patient Preference and Adherence. 9. 1303–1303. 219 indexed citations
16.
Laosa, Olga, et al.. (2014). Pharmaceutical Interventions for Frailty and Sarcopenia. Current Pharmaceutical Design. 20(18). 3068–3082. 24 indexed citations
17.
18.
Ramı́rez, Elena, Olga Laosa, B. Duque, et al.. (2010). Acceptability and characteristics of 124 human bioequivalence studies with active substances classified according to the Biopharmaceutic Classification System. British Journal of Clinical Pharmacology. 70(5). 694–702. 64 indexed citations
19.
Laosa, Olga, et al.. (2009). ESTUDIOS DE BIOEQUIVALENCIA: LA NECESIDAD DE ESTABLECER LA FIABILIDAD DE LOS MEDICAMENTOS GENÉRICOS. SHILAP Revista de lepidopterología. 4 indexed citations
20.
Ramı́rez, Elena, et al.. (2008). The importance of sample size, log-mean ratios, and intrasubject variability in the acceptance criteria of 108 bioequivalence studies. European Journal of Clinical Pharmacology. 64(8). 783–793. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Craig Plauschinat Breakdown of academic impact, for papers by Amy Barton Pai Breakdown of academic impact, for papers by Victoria Rollason Breakdown of academic impact, for papers by Jo E. Rodgers Breakdown of academic impact, for papers by Gayathri Kamalakkannan Breakdown of academic impact, for papers by Sanobar Parkar Breakdown of academic impact, for papers by Andreas D. Meid Breakdown of academic impact, for papers by Morten Hansen Breakdown of academic impact, for papers by Samar A. Nasser Breakdown of academic impact, for papers by Pernelle Noïze
Rankless by CCL
2026